share_log

Eiger BioPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Moshe Arkin(10.15%)

SEC announcement ·  Apr 18, 2023 09:59
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more